zenocutuzumab

Etymology

From zenocu (arbitrary prefix) + -tu- (“tumor”) + -zu- (“humanized”) + -mab (“monoclonal antibody”). See Nomenclature of monoclonal antibodies.

noun

A monoclonal antibody used to treat non-small cell lung cancer or pancreatic cancer.